Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-28

FDA Approved: THIOLA EC — Original Application (Mission Pharmacal Company)

View source ↗

Summary

FDA approved THIOLA EC (tiopronin) as an enteric-coated formulation under Mission Pharmacal Company's original NDA for the prevention of recurrent kidney stone …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • THIOLA EC (tiopronin)

Snippet

ORIG AP for THIOLA EC (TIOPRONIN)